Quest Diagnostics stock rises after Q1 beat (DGX:NYSE)
Summary
Quest Diagnostics (DGX) stock rises as the company lifts its full-year outlook and beats Street forecasts with its Q1 2026 financials. Read more here.
Description
Quest Diagnostics (DGX) stock rises as the company lifts its full-year outlook and beats Street forecasts with its Q1 2026 financials. Read more here.
Original reporting
AFBytes is a read-only aggregator. Use the original source for full context and complete reporting.
Open original source